BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200219T150000
DTEND;TZID=America/New_York:20200219T160000
DTSTAMP:20200208T165510Z
CREATED:20200208T165105Z
LAST-MODIFIED:20200208T165510Z
UID:39162-1582124400-1582128000@globalbiodefense.com
SUMMARY:Public Health Emergency Preparedness (PHEP) Monthly Call
DESCRIPTION:PHEP Recipient Monthly Conference Call Scheduled for February 19 \nCDC’s next monthly conference call with PHEP recipients will be held from 3 p.m. to 4 p.m. EDT on Wednesday\, February 19. Participant information is provided below. \n  \nConference Call Information \nBridge Line: (888) 566-1873 \nParticipant Code: 3358383 \n  \nThe Public Health Emergency Preparedness (PHEP) cooperative agreement is a critical source of funding for state\, local\, and territorial public health departments. Since 2002\, the PHEP cooperative agreement has provided assistance to public health departments across the nation. This helps health departments build and strengthen their abilities to effectively respond to a range of public health threats\, including infectious diseases\, natural disasters\, and biological\, chemical\, nuclear\, and radiological events. Preparedness activities funded by the PHEP cooperative agreement specifically targeted the development of emergency-ready public health departments that are flexible and adaptable.
URL:https://globalbiodefense.com/event/public-health-emergency-preparedness-phep-monthly-call/
LOCATION:DC
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200210T140000
DTEND;TZID=America/New_York:20200210T150000
DTSTAMP:20200126T190837Z
CREATED:20200126T190718Z
LAST-MODIFIED:20200126T190837Z
UID:37779-1581343200-1581346800@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \nh/t NACCHO for originally posting this information.
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness-3/
LOCATION:DC
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200210T133000
DTEND;TZID=America/New_York:20200210T153000
DTSTAMP:20200203T162053Z
CREATED:20200203T161203Z
LAST-MODIFIED:20200203T162053Z
UID:38397-1581341400-1581348600@globalbiodefense.com
SUMMARY:Containing the Coronavirus: Challenges to Thwarting the Outbreak
DESCRIPTION:Hudson Institute and the Bipartisan Commission on Biodefense will host a panel discussion on the ongoing coronavirus outbreak and how the United States can respond to the growing outbreak effectively. \nConfirmed infections of the coronavirus in China have exceeded that of the 2002-2003 SARS epidemic\, with thousands more suspected cases. As the number of cases increases\, concerns are mounting that the global community may not be adequately prepared to prevent the disease from significantly spreading. \nThe virus has already spread to more than 20 countries\, including the United States\, with at least six confirmed cases and more than 100 suspected across 36 states. The Center for Disease Control (CDC) is screening passengers arriving from China at several airports\, but much remains unknown about transmission and symptoms\, and a CDC-developed diagnostic test has yet to be distributed across the country. \nPanel participants will offer their perspectives on the role of the federal government in managing the crisis\, the lack of transparency by the Communist Chinese Government\, implications for U.S national security\, and how the country can better prepare for when the next pandemic strikes. \nThe event will feature U.S. Senator Joe Lieberman\, co-chair of the Bipartisan Commission on Biodefense\, scholars from Hudson Institute\, and other subject matter experts. \nNOTE: This event is open to the press. All members of the media should RSVP to press@hudson.org.
URL:https://globalbiodefense.com/event/containing-the-coronavirus-challenges-to-thwarting-the-outbreak/
LOCATION:Hudson Institute\, 1201 Pennsylvania Avenue Northwest\, #400\, Washington\, DC\, 20004\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200206T173000
DTEND;TZID=America/New_York:20200206T190000
DTSTAMP:20200206T190217Z
CREATED:20200203T163455Z
LAST-MODIFIED:20200206T190217Z
UID:38437-1581010200-1581015600@globalbiodefense.com
SUMMARY:Yale Forum on Outbreak of Novel Coronavirus
DESCRIPTION:In response to news and concerns about the respiratory illness outbreak caused by a novel coronavirus initially identified in China\, the Yale Institute for Global Health\, Yale School of Public Health and the Global Health Justice Partnership will hold a discussion and question and answer session on Thursday\, February 6\, 2020. Panelists will address the epidemiology of the disease\, its impact on public health\, human rights issues and how information on such outbreaks is communicated to the public.\n\nModerator \nSaad Omer\, Director\, Yale Institute for Global Health; Professor of Medicine (Infectious Diseases)\, Yale School of Medicine; Susan Dwight Bliss Professor of Epidemiology of Microbial Diseases\, Yale School of Public Health \nPanelists \nEllen Foxman\, Assistant Professor of Laboratory Medicine and Immunobiology\, Yale School of Medicine \nGregg Gonsalves\, Assistant Professor of Epidemiology; Associate (Adjunct) Professor of Law\, Yale Law School; Co-Director\, Global Health Justice Partnership \nNathan Grubaugh\, Assistant Professor of Epidemiology (Microbial Diseases)\, Yale School of Public Health \nLisa Sanders\, Associate Professor of Medicine (General Medicine)\, Yale School of Medicine; Emmy-award winning television producer\, author of The New York Times column Diagnosis \nDavid Vlahov\, Professor\, PhD Program Director\, Yale School of Nursing \nLive Stream Link \nhttps://yale.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=50702300-d8eb-4398-9d9e-ab530102bbbe
URL:https://globalbiodefense.com/event/yale-forum-on-outbreak-of-novel-coronavirus/
LOCATION:Winslow Auditorium\, 60 College Street\, LEPH 109\, New Haven\, CT\, 06510\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200203T140000
DTEND;TZID=America/New_York:20200203T150000
DTSTAMP:20200126T190909Z
CREATED:20200126T190529Z
LAST-MODIFIED:20200126T190909Z
UID:37776-1580738400-1580742000@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \nh/t NACCHO for originally posting this information.
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness-2/
LOCATION:DC
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200131T140000
DTEND;TZID=America/New_York:20200131T150000
DTSTAMP:20200131T163844Z
CREATED:20200131T143313Z
LAST-MODIFIED:20200131T163844Z
UID:37932-1580479200-1580482800@globalbiodefense.com
SUMMARY:CDC COCA Call: Outbreak of 2019-nCoV: Interim Guidance for Clinicians
DESCRIPTION:The CDC will hold a COCA (Clinicians Outreach and Communication Activity) call this afternoon with their latest recommendations. \n\nDue to the high demand we anticipate for this COCA Call\, we kindly ask participants to access it in a group format\, if at all possible\, to allow for the maximum number of participants to attend. \nTarget audience: \n\nPhysicians\nNurses\nPharmacists\nVeterinarians\nPhysician Assistants\nHealth Educators\nOther Clinicians\n\nPlease note\, there will be only a few introductory slides for this presentation. The subject matter covered during this webinar will not have an accompanying slide deck. \n\nContact Information:coca@cdc.gov\nSupport/Funding:Centers for Disease Control and Prevention\, Emergency Risk Communication Branch\n\nPRESENTERS \nAron Hall\, DVM\, MSPH\n2019-nCoV Epidemiology Task Force Deputy Lead\nNational Center for Immunization and Respiratory Diseases\nCenters for Disease Control and Prevention \nWill Weldon\, PhD\n2019-nCoV Laboratory Task Force Lead\nNational Center for Immunization and Respiratory Diseases\nCenters for Disease Control and Prevention \nTimothy Uyeki\, MD\, MPH\, MPP\n2019-nCoV Response Clinical Team Lead\nNational Center for Immunization and Respiratory Diseases\nCenters for Disease Control and Prevention \nRyan Fagan\, MD\, MPH&TM\n2019-nCoV Healthcare Infection Control Team Lead\nNational Center for Emerging and Zoonotic Infectious Diseases\nCenters for Disease Control and Prevention \nPlease visit the website for call-in information
URL:https://globalbiodefense.com/event/cdc-coca-call-outbreak-of-2019-ncov-interim-guidance-for-clinicians/
LOCATION:DC
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200128
DTEND;VALUE=DATE:20200130
DTSTAMP:20191227T191045Z
CREATED:20191127T185911Z
LAST-MODIFIED:20191227T191045Z
UID:36001-1580169600-1580342399@globalbiodefense.com
SUMMARY:Tick-Borne Disease Working Group (TBDWG)
DESCRIPTION:The 11th meeting of the Tick-borne Disease Working Group (TBDWG) will be held on January 28 and 29\, 2020\, from 9:00 a.m. to 4:30 p.m. ET on both days (times subject to change). \nThe meeting will be held at the in Washington D.C. and by webcast. Preregistration for public members is advisable and can be accomplished by registering here. \nThe TBDWG was established by Congress in 2016 as part of the 21st Century Cures Act to provide subject matter expertise and to review federal efforts related to all tick-borne diseases\, to help ensure interagency coordination and minimize overlap\, and to examine research priorities.  The focus of this effort is the development of a report to the Secretary of Health and Human Services and Congress on the findings and any recommendations of the Working Group for the federal response to tick-borne disease prevention\, treatment and research\, as well as how to address gaps in these areas. \nFor this meeting\, the Working Group will hear presentations from eight subcommittees on their findings and potential actions for the TBDWG to consider; hear updates from the Public Comment and Inventory Subcommittees; and further discuss plans for developing the 2020 report to the HHS Secretary and Congress on federal tick-borne activities and research. \nPublic Comment – Information and Instructions\nThe public will have an opportunity to present their views to the Working Group during the meeting’s public comment session or by submitting their views in writing. \nVerbal comments (in-person): \n\nRequests to provide verbal public comment must be submitted via email by midnight Tuesday\, January 17\, 2020\, ET to tickbornedisease@hhs.gov. In the Subject line please enter: Verbal Public Comment – January 28-29 Meeting. In addition\, please indicate if you will be providing verbal comment in person or by phone. If by phone\, you will be provided a call-in number and and time to call.\nA total of 30 minutes has been set aside for verbal comments on both days. Each person will be limited to 3 minutes in order to accommodate as many speakers as possible. If more requests are received than can be accommodated\, speakers will be randomly selected.\nYour remarks will be heard over a live webcast and will become part of the archived recording and meeting summary that will be posted on this website.\n\nWritten comments \n\nWritten public comments must be submitted via email by midnight Tuesday\, January 17\, 2020\, ET to tickbornedisease@hhs.gov. In the Subject line please enter: Written Public Comment – January 28-29 Meeting.\nWhen you submit your written comment\, please include a statement letting the TBDWG know how you would like to be identified with your comment. You may choose to use your name or to be anonymous. You may also list your city and/or state. If you are providing comments on behalf of an organization\, please include the name of the organization. TBDWG cannot post your comment until you let us know how you would like to be identified.\nComments should either be provided in the body of your email\, or in an attachment in Word format and equivalent to no more than 4 pages in Calibri or Times New Roman\, 11 point font. Text that exceeds the 4 pages will be deleted.\nTBDWG will not post graphics\, images\, text boxes\, or tables. If included with your comment\, they will not be able to retain them.\nTBDWG can only create hyperlinks to “.gov” sites (local\, state\, or federal). For all other reference sites\, please insert the full URL (e.g.\, http://learn.genetics.utah.edu/content/epigenetics).\nTBDWG is also unable to include attachments as supporting documentation to your written comments.\n\n\n\n\nAgenda\nDraft agenda – subject to change. \nDay 1 – January 28\, 2020 \n\n\n\nTime\nAgenda Item\nSpeaker\n\n\n\n\n9:00 am – 9:05 am\n– Welcome from the Working Group\n– Roll Call: During roll call members are asked to state their organization and what subcommittee(s) they co-chair\nLeigh Ann Soltysiak\, Co-Chair\nDavid Walker\, Co-Chair\nJim Berger\, DFO\n\n\n9:05 am – 9:07 am\nOverview of the Working Group’s Mission\, Vision Statement\, Values\nJim Berger\, DFO\n\n\n9:07 am – 9:10 am\n– Update from September 12\, 2019\, Meeting to Today\n– Review 2020 TBDWG objectives\n– What We Hope to Accomplish Today\n– Introduction of Speakers\nLeigh Ann Soltysiak\, Co-Chair\nDavid Walker\, Co-Chair\n\n\n9:15 am – 9:20 am\n– NIH Strategic Plan Update\n– CDC-led Domestic Framework\nSam Perdue\nBen Beard\n\n\n9:20 am – 9:50 am\nPublic Comments\n–\n\n\n9:50 am – 10:00 am\nPublic Comment Subcommittee Update\n– Comments received\n– Overall themes\nScott Commins\, Co-Chair\nAngel Davey\, Co-Chair\nLeigh Ann Soltysiak\, Co-Chair\n\n\n10:00 am – 11:00 am\nSubcommittee Presentation – Tick Biology\, Ecology\, and Control Subcommittee\nKevin Macaluso\, Co-Chair\nBeto Perez de Leon\, Co-Chair\n\n\n11:00 am – 11:15 am\nBreak\n–\n\n\n11:15 am – 12:15 pm\nSubcommittee Presentation – Pathogenesis and Physiology of Lyme Disease Subcommittee\nSam Donta\, Co-Chair\nLeith States\, Co-Chair\n\n\n12:15 pm – 1:15 pm\nSubcommittee Presentation – Clinical Aspects of Lyme Disease Subcommittee\nCDR Rebecca Bunnell\, Co-Chair\nSam Donta\, Co-Chair\n\n\n1:15 pm – 2:15 pm\nLunch\n–\n\n\n2:15 pm – 3:15 pm\nSubcommittee Presentation – Training\, Education\, Access to Care\, and Reimbursement Subcommittee\nCDR Rebecca Bunnell\, Co-Chair\nPat Smith\, Co-Chair\n\n\n3:15 pm – 4:15 pm\nSubcommittee Presentation – Alpha-gal Subcommittee\nScott Commins\, Co-Chair\nAngel Davey\, Co-Chair\nLeigh Ann Soltysiak\, Co-Chair\n\n\n4:15 pm\nAdjourn\n–\n\n\n\nDay 2 – January 29\, 2020 \n\n\n\nTime\nAgenda Item\nSpeaker\n\n\n\n\n9:00 am – 9:05 am\nWelcome from the Working Group\nLeigh Ann Soltysiak\, Co-Chair\nDavid Walker\, Co-Chair\n\n\n9:05 am – 9:07 am\nRecap of First Day\nJim Berger\, DFO\n\n\n9:07 am – 9:37 am\nPublic Comments\n–\n\n\n9:37 am – 10:37 am\nSubcommittee Presentation – Babesiosis and Tick-Borne Pathogens Subcommittee\nBen Beard\, Co-Chair\nGene Shapiro\, Co-Chair\n\n\n10:37 am – 10:52 am\nBreak\n–\n\n\n10:52 am – 11:52 am\nSubcommittee Presentation – Ehrlichiosis and Anaplasmosis Subcommittee\nDennis Dixon\, Co-Chair\nDavid Walker\, Co-Chair\n\n\n11:52 am – 12:52 pm\nSubcommittee Presentation – Rickettsiosis Subcommittee\nEstella Jones\, Co-Chair\nDavid Walker\, Co-Chair\n\n\n12:52 pm – 1:52 pm\nLunch\n–\n\n\n1:52 pm – 1:57 pm\nFederal Inventory Update\n– What has been received\n– What is outstanding\nJim Berger\, DFO\n\n\n1:57 pm – 3:07 pm\nOpen Discussions for Working Group\nWorking Group\n\n\n3:07 pm – 3:22 pm\nBreak\n–\n\n\n3:22 pm – 3:52 pm\nDiscussion of Next Steps and What is Expected for the March Meeting\nLeigh Ann Soltysiak\, Co-Chair\nDavid Walker\, Co-Chair\n\n\n3:52 pm – 3:57 pm\nReview Draft Outline of Report to Congress\nWorking Group\n\n\n3:57 pm – 4:30 pm\nOpen Discussion for Working Group\nWorking Group\n\n\n4:30 pm\nAdjourn\n–\n\n\n\nPlease view the Federal Register Meeting Notice and visit the meeting page for the latest information. \n 
URL:https://globalbiodefense.com/event/tick-borne-disease-working-group-tbdwg/
LOCATION:Hyatt Place Washington DC/US Capitol\, 33 New York Avenue\, Washington\, DC\, 20002\, United States
CATEGORIES:Policy-Legislative,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2014/05/tick_amber_ancient_lyme.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200127T140000
DTEND;TZID=America/New_York:20200127T150000
DTSTAMP:20200126T224608Z
CREATED:20200124T185703Z
LAST-MODIFIED:20200126T224608Z
UID:37773-1580133600-1580137200@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \n(h/t NACCHO for originally posting this information.)
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness/
LOCATION:DC
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200126T110000
DTEND;TZID=America/New_York:20200126T140000
DTSTAMP:20201127T192409Z
CREATED:20201127T192409Z
LAST-MODIFIED:20201127T192409Z
UID:48057-1580036400-1580047200@globalbiodefense.com
SUMMARY:Envisioning a Transformed Clinical Trials Enterprise for 2030
DESCRIPTION:The National Academies’ Forum on Drug Discovery\, Development\, and Translation will host a virtual public workshop on Jan 26\, 2021 as part of a web series forum of events to discuss critical policy for advancement of biopharmaceutical innovation nationally and globally. \nThis virtual public workshop will provide a venue for stakeholders to consider a transformed clinical trial enterprise for 2030. Workshop participants will consider lessons learned from progress and setbacks over the past 10 years\, since the previous workshop\, Envisioning a Transformed Clinical Trials Enterprise in the United States\, and\, looking forward\, discuss goals and key priorities for advancing a clinical trials enterprise that is more efficient\, effective\, person-centered\, inclusive\, and integrated into the health delivery system of 2030. \nThe event will provide an overview discussion on how an envisioned 2030 clinical trials enterprise may differ from the current system. It will discuss key challenges and opportunities in improving person-centeredness and inclusivity\, building resilience and transparency\, and integrating new technologies. \nThe workshop session will consider changes in the clinical trials enterprise made in response to COVID-19 that may establish positive and sustainable examples for the future\, and consider specific action steps that individual stakeholders could take to support an envisioned change from 2020 to 2030. \nFor additional information on the workshop series\, please visit the project page. \nBackground\nClinical trials research has changed dramatically over the last decade. The biological\, physical\, and digital spheres are merging; clinical research and health care are at a critical juncture; new approaches enable the collection of data in real-world settings; and new modalities\, such as digital health technologies and artificial intelligence applications\, are changing possibilities for the conduct of clinical research. These opportunities hold great promise for advancing our understanding of health maintenance and prevention\, disease progression\, and developing new therapies for patients. At the same time\, the clinical research enterprise is strained by rising costs\, an evolving regulatory and economic landscape\, increasing clinical trial complexity\, difficulties in the recruitment and retention of research participants\, and a clinical research workforce that is under tremendous stress. Some\, but not all\, of these challenges and opportunities were predicted in the 2011 National Academies workshop\, Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020. There is now a need for stakeholders from across the clinical research lifecycle to consider lessons learned from progress and setbacks over the past 10 years and broadly consider goals and key priorities for advancing a clinical trials enterprise that is more efficient\, effective\, person-centered\, inclusive\, and integrated into the health delivery system of 2030.
URL:https://globalbiodefense.com/event/envisioning-a-transformed-clinical-trials-enterprise-for-2030/
LOCATION:https://bit.ly/nasem-clinicaltrialenterprise
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200123
DTEND;VALUE=DATE:20200125
DTSTAMP:20200105T182855Z
CREATED:20191205T175457Z
LAST-MODIFIED:20200105T182855Z
UID:36104-1579737600-1579910399@globalbiodefense.com
SUMMARY:National Science Advisory Board for Biosecurity (NSABB) Meeting
DESCRIPTION:The National Science Advisory Board for Biosecurity (NSABB) will convene 23-24 January 2020 in Bethesda\, Md. \nThe meeting will be open to the public\, with attendance limited to space available. The meeting will also be videocast. \nJanuary 23: 12:30 PM – 5 PM Eastern\nJanuary 24: 9 AM – 2:30 PM Eastern \nThe purpose of this meeting is to discuss considerations regarding security and public transparency when sharing information about research involving enhanced potential pandemic pathogens; as well as other business of the Board. \nIf you plan to attend the meeting in person please pre-register HERE.\nIndividuals in attendance may also register onsite on the day of the meeting.\nDraft Agenda will be posted when available. \nVideocasts: \n\nDay 1 – Link will be available on January 23\, 2020\nDay 2 – Link will be available on January 24\, 2020\n\nPlease visit the website for more information: http://bit.ly/NSABB-Meetings \nCurrent Voting Board Members\nMargie D. Lee\, DVM\, PhD*\nProfessor and Head\, Department of Biomedical Sciences and Pathobiology\nVirginia-Maryland College of Veterinary Medicine\nVirginia Tech \nStephen S. Morse\, PhD*\nDirector\, Infectious Disease Epidemiology Certificate Program\nProfessor of Epidemiology\nMailman School of Public Health\nColumbia University \nJean L. Patterson\, PhD\nProfessor\, Virology and Immunology Chair\, BSL-4 Task Force\nTexas Biomedical Research Institute \nRozanne M. Sandri-Goldin\, PhD\nProfessor and Chair\, Department of Microbiology and\nMolecular Genetics\nUniversity of California Irvine School of Medicine \nKenneth Bernard\, MD\nRADM\, U.S. Public Health Service (Ret.)\nFormer Special Assistant to the President for Biodefense\, Homeland Security Council\, White House\nFormer Special Adviser for Health and Security on the National Security Council \nCraig E. Cameron\, PhD\nJeffrey Houpt Distinguished Investigator\nChair\, Department of Microbiology and Immunology\nUniversity of North Carolina Chapel Hill School of Medicine \nMark Denison\, MD\nProfessor and Chair of Pediatrics\nAssociate Professor of Microbiology and Immunology\nVanderbilt University School of Medicine \nJohn D. Grabenstein\, RPh\, PhD\nSenior Medical Director\, Adult Vaccines\nMerck Vaccine Division\nMerck & Co.\, Inc. \nMarie-Louise Hammarskjöld\, MD\, PhD\nCharles H. Ross Jr. Professor and Professor of Microbiology\, Immunology\, and Cancer Biology\nAssociate Director\, Myles H. Thaler Center\nUniversity of Virginia School of Medicine \nJames W. LeDuc\, PhD\nDirector\, Galveston National Laboratory\nProfessor\, Department of Microbiology and Immunology\nUniversity of Texas Medical Branch
URL:https://globalbiodefense.com/event/national-science-advisory-board-for-biosecurity-nsabb-meeting/
LOCATION:Hyatt Regency Bethesda\, One Bethesda Metro Center\, Bethesda\, MD\, 20814\, United States
CATEGORIES:Conference,Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191204
DTEND;VALUE=DATE:20191205
DTSTAMP:20191204T193020Z
CREATED:20191102T054424Z
LAST-MODIFIED:20191204T193020Z
UID:34810-1575417600-1575503999@globalbiodefense.com
SUMMARY:Personalized Protective Biosystem (PPB) Proposers Day
DESCRIPTION:The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is holding a Proposers Day meeting and webinar covering the new Personalized Protective Biosystem (PPB) program on Dec 4\, 2019 in Arlington\, Va. \nPPB aims to develop technology that reduces the need for burdensome protective equipment while increasing individual protection against chemical and biological threats. The program comprises two technical areas: 1) reactive materials that prevent threat agent access to the body; 2) a configurable barrier countermeasure that neutralizes threat agents at vulnerable points of entry (i.e.\, skin\, airway\, ocular). \nAdditional details\, including registration instructions\, are available at https://go.usa.gov/xp8dU. The registration deadline is November 26\, 2019\, at 12:00 PM EST or when capacity is reached. Registrations for webinar attendance only are accepted through December 2\, 2019\, or until webinar capacity is reached. \nDARPA hosts Proposers Days to provide potential performers with information on whether and how they might respond to the Government’s research and development solicitations and to increase efficiency in proposal preparation and evaluation. Therefore\, the PPB Proposers Day is open only to registered potential applicants\, and not to the media or general public. \nDARPA anticipates sharing additional program details in a forthcoming Broad Agency Announcement to be posted to the https://beta.sam.gov/ website.
URL:https://globalbiodefense.com/event/personalized-protective-biosystem-ppb-proposers-day/
LOCATION:George Mason University Arlington Campus\, 3351 Fairfax Dr\, Arlington\, VA\, 22201\, United States
CATEGORIES:Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/12/cbrne-darpa-ppb-personalized-protective-biosystem.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191121T140000
DTEND;TZID=America/New_York:20191121T153000
DTSTAMP:20190927T181033Z
CREATED:20190927T181033Z
LAST-MODIFIED:20190927T181033Z
UID:30701-1574344800-1574350200@globalbiodefense.com
SUMMARY:Ebola and Beyond: Legal Preparedness for Outbreaks
DESCRIPTION:A webinar on the Legal Preparedness for Outbreaks will be held 21 Nov 2019 at 2:00pm Eastern. \nThe discussion will examine challenges public health professionals and responders are facing during the Ebola response\, as well as current legal provisions and concepts and how to apply them to future infectious disease emergency response planning. In addition\, as studies show vulnerable populations are the most significantly impacted when disasters strike\, this webinar will highlight protection of vulnerable populations for the next communicable disease outbreak of public health concern. \nThe webinar is the 3rd in a 4-part series on Legal Preparedness for Public Health Emergencies hosted under a collaborative effort by the National Governors Association\, U.S. Centers for Disease Control and Prevention and the American Bar Association. \nRegister here.
URL:https://globalbiodefense.com/event/ebola-and-beyond-legal-preparedness-for-outbreaks/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191121T090000
DTEND;TZID=America/New_York:20191121T103000
DTSTAMP:20191115T041744Z
CREATED:20191115T041446Z
LAST-MODIFIED:20191115T041744Z
UID:33870-1574326800-1574332200@globalbiodefense.com
SUMMARY:All of Us: How Public Health Can Learn From and Inform the Precision Medicine
DESCRIPTION:The Office of Genomics and Precision Public Health\, Office of Science\, Centers for Disease Control and Prevention will host a Webinar on 21 Nov 2019 on the All of Us research program. \nThe National Institute of Health (NIH)-led All of Us research program aims to enroll over one million people in the U.S. in a research cohort to improve understanding of how individual differences in lifestyle\, socioeconomics\, environment\, and biology affect health outcomes. \nRecruiting a diverse research cohort is key to ensuring that findings will be broadly applicable\, and All of Us strives to include participants from groups historically underrepresented in biomedical research. Join us to learn more about the All of Us research program\, better understand how the approaches used to recruit All of Us participants can inform future public health efforts to address diversity\, and share your expertise in increasing diverse participation in your own public health work. \nFree Online Webinar\nRegistration is required. Please register.\nView the Webinar via Skype\nPhone: (855) 644-0229\, Conference ID: 4390261
URL:https://globalbiodefense.com/event/all-of-us-how-public-health-can-learn-from-and-inform-the-precision-medicine/
LOCATION:Centers for Disease Control and Prevention\, 1600 Clifton Road\, Atlanta\, GA\, 30329\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191028
DTEND;VALUE=DATE:20191029
DTSTAMP:20191020T223743Z
CREATED:20191020T223743Z
LAST-MODIFIED:20191020T223743Z
UID:31050-1572220800-1572307199@globalbiodefense.com
SUMMARY:DARPA Proposers Day: Nucleic Acids On-Demand Worldwide (NOW)
DESCRIPTION:The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) will host a Proposers’ Day on October 28\, 2019 in Arlington\, Virginia. \nThe event will gather the planned proposer community in support of the Nucleic Acids On-Demand Worldwide (NOW) program\, which aims to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to rapidly produce\, formulate\, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA). \nThe Proposers Day will include brief overview presentations by government personnel\, an\ninformation session to respond to questions from participants\, “lightning” talks (three minutes\,\none PowerPoint slide)\, posters for potential proposers to highlight technical capabilities or to\npromote teaming\, and private sidebar meetings between the DARPA government team and\npotential proposer teams. \nParticipant presentations and sidebar meetings must be scheduled via the registration website. Lightning talk presentations will be made accessible to the proposer community on the NOW program website after presentation at the Proposers day. It is expected that NOW will require strong teaming efforts to successfully innovate and integrate critical technologies necessary to meet the metrics of the NOW program. \nAttendance at this event is not a requirement for submission of a proposal or selection for\nfunding. Information relayed during the Proposers Day will be made available on the BTO\nsection of the DARPA Opportunities page. \nAttendance is open to individuals who are U.S. Citizens\, U.S. Permanent Residents\, and Foreign Nationals. Upon entry to the physical meeting\, all attendees will be required to present valid\, Government-issued photo identification. \nREGISTER HERE. Registration for physical participation will close on October 23\, 2019 at 12:00 PM ET (updated from original date of October 21\, 2019 at 12:00 PM ET) or when capacity is reached and webinar participation will close on October 25\, 2019 at 12:00 PM ET or when webinar capacity is reached\, whichever comes first.Registration is limited by the venue capacity\, and early registration is strongly recommended. There will be no on-site registration. \nGlobal Biodefense is a publisher providing visibility on this important development program. For all attendance or logistics information\, please contact the event sponsor.
URL:https://globalbiodefense.com/event/darpa-proposers-day-nucleic-acids-on-demand-worldwide-now/
LOCATION:Executive Conference Center (ECC)\, 4075 Wilson Boulevard\, Arlington\, VA\, 22203\, United States
CATEGORIES:Industry Day,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190911T090000
DTEND;TZID=America/New_York:20190911T170000
DTSTAMP:20190906T150226Z
CREATED:20190906T144340Z
LAST-MODIFIED:20190906T150226Z
UID:30253-1568192400-1568221200@globalbiodefense.com
SUMMARY:National Biodefense Science Board: Public Meeting
DESCRIPTION:The HHS Office of the Secretary is hosting the National Biodefense Science Board (NBSB) Public Meeting in Washington\, DC\, on September 11\, 2019. The meeting is also available for remote participation by teleconference. \nThe purpose of the meeting is to gather information to develop expert advice provided by NBSB and guidance to the Secretary on scientific\, technical\, and other matters of special interest to HHS regarding current and future chemical\, biological\, nuclear\, and radiological (CBRN) agents\, whether naturally occurring\, accidental\, or deliberate. \nAgenda items include: \n\nPresentation from the Disaster Medicine Working Group (DMWG)\nExploring Issues in Biodefense Science: Development and Use of Animal Models to Enhance Rapid Approval of Novel MCM\nASPR Program Update: Vision for the Pediatric Disaster Care Centers of Excellence Cooperative Agreement\n\nTeleconference Information:\nToll Numbers (International Callers): 773-799-3992\nToll Free Number: 888-417-0384\nParticipant passcode: 3609874 (Listen only; Public callers\, use for the public NBSB phe.gov site) \nFor further information contact: CAPT Christopher Perdue\, MD\, MPH\, Designated Federal Official\, NBSB\, ASPR\, HHS; 202-401-5837; christopher.perdue@hhs.gov
URL:https://globalbiodefense.com/event/national-biodefense-science-board-public-meeting/
LOCATION:O’Neil Building\, 200 C Street SW\, Washington\, DC\, 20515
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/09/national-biodefense-science-board.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190911
DTEND;VALUE=DATE:20190913
DTSTAMP:20190817T225348Z
CREATED:20190817T224214Z
LAST-MODIFIED:20190817T225348Z
UID:30036-1568160000-1568332799@globalbiodefense.com
SUMMARY:2019 FDA Science Forum
DESCRIPTION:The 2019 FDA Science Forum will be held on 11-12 September 2019 in Silver Spring\, Md. The event may be attended in-person or via Webcast (pre-registration is required). \nFDA’s Science Forum welcomes the public\, industry\, academia\, patient advocates\, sister agencies\, and current and potential collaborator to learn how FDA’s researchers are using novel science and technologies to inform FDA’s regulatory decision-making—and drive innovation. \nAgenda items of interest highlighted by the Global Biodefense staff include: \n\nEmerging & Pandemic Threat Preparedness\nBio-Terrorism Regulations and Food Security\nFDA Food Defense Efforts – A Preventive Approach to Food Terrorism\nCBER-Regulated Products: Preventing and Mitigating Shortages\nViolent Non-State Actor Use of Food as a Delivery System: Comparing ideological and Non-Ideological Perpetrators\nProduct Availability: A Drug Shortage Perspective\nMetagenomeTrakr Pilot Program for Rapid Foodborne Pathogen Detection\nAvian Influenza A Susceptibilities to Pulmonary Surfactant Protein D: Confirmation of N-glycan sub-type as a Pathogenic Factor in Influenza\nImmune Responses to Zika Infections\nInnovation in Science: Protecting People from Emerging Infectious Disease Threats\nFoodborne Outbreak Investigations in the Whole Genome Sequencing Era\nTracking antibiotic resistance in Salmonella: The role of the National Antimicrobial Resistance Monitoring System\nDeep Learning for Polypharmacy and Drug Repurposing\nC. elegans for Rapid Developmental Neurotoxicity Assessment of Mixtures\nCardiac and Hepatic Cellular Systems to Model Human Drug Effects\nThe VICTRE Project: The First All-In-Silico Imaging Clinical Trial\nDigital Biomarkers Discovery from Patient-Generated Health Data\nAI at FDA: Potential Utility and Regulatory Challenges\nAdvancing Digital Health and Artificial Intelligence\nImpacting Public Health Through Electronic Media: Empowering Consumers\, Patients\, and Other Stakeholders\nMetagenomeTrakr Pilot Program for Rapid Foodborne Pathogen Detection\nPreclinical pharmacology of novel synthetic opioids appearing in clandestine drug markets\nAssessing the structural and pharmacological similarity of newly identified drugs of abuse to controlled substances using PHASE\nAccelerating Innovation in Manufacturing Technology for Biomanufactured Products: Manufacturing U.S. and NIST\nOn the ‘Cyber-Securability’ of Medical Devices\n\nPlease visit the FDA Science Forum website to view the full agenda and register.
URL:https://globalbiodefense.com/event/2019-fda-science-forum/
LOCATION:FDA White Oak Campus\, 10903 New Hampshire Ave\, Silver Spring\, MD\, 20993\, United States
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/08/2019-fda-science-forum.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190724T130000
DTEND;TZID=America/New_York:20190724T141500
DTSTAMP:20190621T172628Z
CREATED:20190621T172318Z
LAST-MODIFIED:20190621T172628Z
UID:29336-1563973200-1563977700@globalbiodefense.com
SUMMARY:Social Media Monitoring in Public Health Emergencies Webinar
DESCRIPTION:The National Association of County and City Health Officials (NACCHO) will “Social Media Monitoring in Public Health Emergencies” webinar on 24 July 2019 as part of a webinar series to help local health departments build capacity to engage in public health communication. \nHosted by and presented by the New York City Department of Health and Mental Hygiene\, “Social Media Monitoring in Public Health Emergencies“ will help participants learn how to use social media to monitor and respond to the spread of (mis)information during public health emergencies. Presenters will: \n\ndescribe the importance of being aware of public sentiment during a public health emergency;\nidentify how to use social media bidirectionally to both provide updates and collect public feedback; and\nshare scalable approaches for managing social media monitoring regardless of organizational budget.\n\nThe webinar will be recorded for on-demand viewing. REGISTER TO JOIN.\nTo view and register for the remainder of the webinars\, click here. If you have questions about this webinar series or are interested in joining NACCHO’s Public Health Communications Collaborative—a community of practice for public information officers and the like—please email Kim Rodgers.
URL:https://globalbiodefense.com/event/social-media-monitoring-in-public-health-emergencies-webinar-series/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190718T143000
DTEND;TZID=America/New_York:20190718T154500
DTSTAMP:20190621T172956Z
CREATED:20190521T172808Z
LAST-MODIFIED:20190621T172956Z
UID:29335-1563460200-1563464700@globalbiodefense.com
SUMMARY:Managing Media Relations During a Public Health Emergency
DESCRIPTION:For the second year in a row\, NACCHO is pleased to host a multi-part webinar series to help local health departments build capacity to engage in public health communication. Coordinated by NACCHO and the National Public Health Information Coalition (NPHIC)\, “Managing Media Relations” will help participants learn basic media relations principles; understand what NOT to say; understand how to change the conversation to YOUR message; and where to look for help when things go wrong. \nLearning Objectives \n\nIntroduce basic principles of interacting with and pitching local media\nUnderstand different types of media communications tactics\, (e.g.\, press releases\, backgrounders\, media advisories and press briefings)\nLearn best practices for educating media partners on health topics/data to avoid inaccuracy\n\nFeatured Speakers \n\nRichard Sheehe\, Senior Strategist\, The Merritt Group & Senior Research Fellow\, George Washington University\nKristina Wieghmink\, M.Ed.\, Communication Specialist/Public Information Officer\, Ottawa County Dept. of Public Health\n\nThe webinar will be recorded for on-demand viewing. REGISTER TO JOIN.
URL:https://globalbiodefense.com/event/managing-media-relations-during-a-public-health-emergency/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190619T140000
DTEND;TZID=America/New_York:20190619T150000
DTSTAMP:20190621T173200Z
CREATED:20190421T173111Z
LAST-MODIFIED:20190621T173200Z
UID:29292-1560952800-1560956400@globalbiodefense.com
SUMMARY:Webinar: Local Health Department Role in Containment of Novel Resistance
DESCRIPTION:As issues with drug resistant pathogens have emerged across the country\, local health departments have been called on to lead and support the containment of novel or targeted multidrug-resistant organisms (MDROs). Join NACCHO to learn more about the experiences of three local health departments who have been affected by containment events. \nBy the end of this webinar\, participants will be able to: \n\nDescribe the experiences of three local health departments supporting containment responses\nIdentify the role of local health departments in containment of MDROs\nDiscuss how other local health departments may prepare for similar events\n\nREGISTER.
URL:https://globalbiodefense.com/event/webinar-local-health-department-role-in-containment-of-novel-resistance/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190612T140000
DTEND;TZID=America/New_York:20190612T150000
DTSTAMP:20190428T220121Z
CREATED:20190428T215932Z
LAST-MODIFIED:20190428T220121Z
UID:26501-1560348000-1560351600@globalbiodefense.com
SUMMARY:Cross-Sector Collaboration to Implement Health in All Policies (HiAP)
DESCRIPTION:NACCHO is hosting a Health in All Policies (HiAP) webinar series for local health departments. The goal of the webinar series is to provide an open\, informal space for dialogue and peer-to-peer sharing about challenges and best practices. \nThe webinars take place on the second Wednesday of the month\, and each month has a different theme. Each webinar in the series will be recorded and posted to NACCHO’s HiAP webpage; however\, the best way to ensure your questions are answered is to attend the webinar and participate in the discussion. \nWebinar 6: Cross-sector Collaboration to Implement HiAP\nWednesday\, June 12; 2:00-3:00pm ET \nThe webinar will provide an overview of Boston’s Health Equity in All Policies Taskforce and City of Boston departments efforts to apply racial and health equity lens to city programs and services\, with examples from Boston’s sidewalk equity\, public works and transportation equity work. \nRegister now.
URL:https://globalbiodefense.com/event/cross-sector-collaboration-to-implement-health-in-all-policies-hiap/
LOCATION:Online
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190515T190000
DTEND;TZID=America/New_York:20190515T200000
DTSTAMP:20190501T172329Z
CREATED:20190317T231744Z
LAST-MODIFIED:20190501T172329Z
UID:25407-1557946800-1557950400@globalbiodefense.com
SUMMARY:Emerging Infectious Diseases of Wildlife: A Biosecurity Threat
DESCRIPTION:A ChABSA Technical Seminar will be held in Gaithersburg MD and by webcast on 15 May 2019 on Emerging Infectious Diseases of Wildlife: A Biosecurity Threat. \nSpeaker Bio \nDr. Karen Lips\, Professor of Biology at the University of Maryland is the presenter. She has a B.S. in Zoology from the University of South Florida\, and a Ph.D. in Biology from the University of Miami. She is a field ecologist who studies how global change affects biodiversity. She is interested in how the loss of biodiversity affects communities and ecosystems\, and how human activities contribute to the spread of disease and loss of biodiversity. Dr. Lips was a Jefferson Science Fellow at the Department of State\, where she worked in the Bureau of Western Hemisphere Affairs\, in the Office of Public Diplomacy and Public Affairs\, and where she served as an Embassy Science Fellow in Colombia. Dr. Lips is a Research Associate at the US Museum of Natural History\, an AAAS Leshner Leadership Public Engagement Fellow\, an AAAS Fellow\, an ESA Fellow\, and an Aldo Leopold Leadership Fellow. She was awarded the President’s Award of the Chicago Zoological Society\, a Bay and Paul Biodiversity Leadership Award\, the Sabin Amphibian Conservation Award in 2012\, and the inaugural UMD Impact Communicator Award. Dr. Lips is interested in increasing engagement on environmental issues\, promoting scientific leadership\, and fostering international scientific collaborations.
URL:https://globalbiodefense.com/event/emerging-infectious-diseases-of-wildlife-a-biosecurity-threat/
LOCATION:Medimmune\, One Medimmune Way\, Gaithersburg\, MD\, 20878\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190506
DTEND;VALUE=DATE:20190507
DTSTAMP:20190429T045256Z
CREATED:20190407T023001Z
LAST-MODIFIED:20190429T045256Z
UID:25856-1557100800-1557187199@globalbiodefense.com
SUMMARY:National Network of Libraries of Medicine Wikipedia Edit-a-Thon
DESCRIPTION:The National Network of Libraries of Medicine (NNLM) is continuing its efforts to improve consumer health information on Wikipedia with its third Edit-a-Thon on May 6\, 2019. \nUsing trusted National Library of Medicine resources like PubMed\, MedlinePlus\, and Genetics Home Reference\, NNLM will be working to add citations to existing Wikipedia articles related to health equity. \nCheck out nnlm.gov/wiki to learn more about the event and make sure to follow along on Twitter throughout the day with the hashtag #citeNLM to ask questions\, post photos\, and share your Wikipedia experience. See you on May 6! \nEditor’s note: Please follow their lead and lend your expertise in Infectious Diseases to improve Wikipedia entries.
URL:https://globalbiodefense.com/event/nnlm-spring-2019-wikipedia-edit-a-thon/
LOCATION:Online
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190313
DTEND;VALUE=DATE:20190314
DTSTAMP:20190308T222641Z
CREATED:20190304T173047Z
LAST-MODIFIED:20190308T222641Z
UID:24529-1552435200-1552521599@globalbiodefense.com
SUMMARY:CDC Second Wednesday Webinar: Medical Countermeasure Planning
DESCRIPTION:The U.S. Centers for Disease Control and Prevention (CDC) will present the March Second Wednesday Webinar from 1 p.m. to 2 p.m. EDT on Wednesday\, March 13. The presentation will highlight anthrax and pandemic influenza readiness key components in preparation for the next Public Health Emergency Preparedness (PHEP) cooperative agreement performance period. \nRegistration is not required to join this webinar via Adobe Connect. Participants can log onto https://adobeconnect.cdc.gov/r6ooog3mlz5/ to view the webinar. To listen to the audio portion via a phone line\, dial 1-888-455-3007 and enter participant passcode 4330935. \nCEUs will not be offered for this presentation. For more information on the Second Wednesday Webinar series\, contact preparedness@cdc.gov \nBackground: PHEP is a critical source of funding for state\, local\, and territorial public health departments. Since 2002\, the PHEP cooperative agreement has provided assistance to public health departments across the nation. This helps health departments build and strengthen their abilities to effectively respond to a range of public health threats\, including infectious diseases\, natural disasters\, and biological\, chemical\, nuclear\, and radiological events. Preparedness activities funded by the PHEP cooperative agreement specifically targeted the development of emergency-ready public health departments that are flexible and adaptable. \nIn response to the 2009 H1N1 influenza pandemic\, CDC also helped communities through the Public Health Emergency Response grant to increase state and local preparedness and response capacity during the pandemic. The recipients included the 62 PHEP awardees.
URL:https://globalbiodefense.com/event/cdc-second-wednesday-webinar-medical-countermeasure-planning/
LOCATION:Webinar
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/03/cdc-medical-countermeasure-planning-webinar-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20190312T190000
DTEND;TZID=America/Los_Angeles:20190312T200000
DTSTAMP:20190310T002256Z
CREATED:20190210T195745Z
LAST-MODIFIED:20190310T002256Z
UID:21875-1552417200-1552420800@globalbiodefense.com
SUMMARY:Biosafety Concerns of Cell Sorting: Policies\, Procedures\, and PPE
DESCRIPTION:The ChABSA will host a technical seminar by Drs. Kristen Reifel and Brandon Swan on the biosafety concerns involved in cell sorting on March 12\, 2019 in Frederick\, Md. Remote participation is available via webcast. \nDr. Kristen M. Reifel is a Principal Investigator in the Genomics group at the National Biodefense Analysis and Countermeasures Center (NBACC). She is also a member of the International Society for Advancement of Cytometry (ISAC) Biosafety Committee\, and recently selected as an ISAC Shared Resource Laboratory Emerging Leader. \nDr. Brandon K. Swan is a Principal Investigator in the Genomics group at NBACC. He received his PhD in Marine Science from the University of California\, Santa Barbara and was a Postdoctoral Fellow at the Single Cell Genomics Center located at the Bigelow Laboratory for Ocean Sciences\, the first user facility established for single cell genomic sequencing. \nRegistration for the event is required. \nThe Chesapeake Area Biological Safety Association (ChABSA)\, is an incorporated\, non-profit organization that is an affiliate of the American Biological Safety Association (ABSA). ChABSA was established in 1987 by local area members of ABSA with a similar interest in the safety of research using microorganisms and recombinant DNA.
URL:https://globalbiodefense.com/event/biosafety-concerns-of-cell-sorting-policies-procedures-and-ppe/
LOCATION:Hood College Coblentz Hall\, 650 Blazer Trail\, Frederick\, MD\, 21701\, United States
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/02/biosafety-concerns-cell-sorting.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190312T130000
DTEND;TZID=America/New_York:20190312T140000
DTSTAMP:20190309T183541Z
CREATED:20190215T182040Z
LAST-MODIFIED:20190309T183541Z
UID:24618-1552395600-1552399200@globalbiodefense.com
SUMMARY:Planning Webinar: Tools and Resources for Upcoming National Infant Immunization Week
DESCRIPTION:Join the Centers for Disease Control and Prevention (CDC) for a planning webinar on 12 March 2019 to learn about National Infant Immunization Week planning tools\, digital communication resources\, and how to get involved with CDC activities planned for the week. \nThis year marks the 25th anniversary of National Infant Immunization Week (NIIW). From April 27-May 4\, 2019\, NIIW will highlight the importance of protecting infants from vaccine-preventable diseases and will celebrate the achievements of immunization programs in promoting healthy communities throughout the United States. \nPlease visit the registration website and sign up today.
URL:https://globalbiodefense.com/event/planning-webinar-tools-and-resources-for-upcoming-national-infant-immunization-week/
LOCATION:Webinar
CATEGORIES:Awareness Event,Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/03/national-infant-immunization-week.png
ORGANIZER;CN="Public Health Foundation":MAILTO:info@phf.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190312
DTEND;VALUE=DATE:20190314
DTSTAMP:20220906T195454Z
CREATED:20190208T212321Z
LAST-MODIFIED:20220906T195454Z
UID:23475-1552348800-1552521599@globalbiodefense.com
SUMMARY:Long-Term Health Monitoring following Nuclear & Radiological Emergencies
DESCRIPTION:The National Academies’ Nuclear and Radiation Studies Board (NRSB) will host “Challenges in Initiating and Conducting Long-Term Health Monitoring of Populations following Nuclear and Radiological Emergencies in the United States: A Workshop” on 12-13 March 2019 in Washington\, D.C. \nWorkshop participants will discuss the following topics: \n\nEnvironmental Consequences of Radioactive Material following a Nuclear or Radiological Incident\nThe need to Prepare for Population Monitoring\nRadiation Dose Reconstruction\nBiodosimetry Tools for Long-Term Health Monitoring\nFollow-up of the Atomic Bombing Survivors\nCommunicating Health Monitoring Following the Salisbury Nerve Agent Attack\nThe Chernobyl Registry\nDosimetry During the Radiological Accident in Goiânia\nThe Fukushima Registry\nRadiation Screening/Decontamination\nMedical Management of Radiation Incidents\nLong-Term Strategies for Thyroid Health Monitoring after Nuclear Accidents\nLessons Learned from Setting up Population Monitoring Registries\nThe Las Vegas Mass Shooting\nOperational Considerations for Setting up and Maintaining a Radiation Registry\n\nAttend in-person or via webcast. Please visit the event registration page for more information.
URL:https://globalbiodefense.com/event/long-term-health-monitoring-following-nuclear-radiological-emergencies/
LOCATION:Keck Center\, 500 5th Street Northwest\, Washington\, DC\, 20001\, United States
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/03/nuclear-radiation-studies-board-12mar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190305
DTEND;VALUE=DATE:20190307
DTSTAMP:20190429T044246Z
CREATED:20190224T202524Z
LAST-MODIFIED:20190429T044246Z
UID:23766-1551744000-1551916799@globalbiodefense.com
SUMMARY:Vaccine Strategies for Endemic Fungal Pathogens
DESCRIPTION:The National Institute of Allergy and Infectious Diseases (NIAID) will host a Vaccine Strategies for Endemic Fungal Pathogens meeting on 5-6 March 2019 to discuss the scope of endemic fungal disease\, learn about the latest discoveries\, and determine actionable steps to advance fungal vaccines. \nThis meeting will take place at the NIAID Conference Center in Rockville\, Maryland and also be webcast. Please indicate when registering whether you will be attending in person or via webcast. Editor’s note: This event registration is now closed (1 Mar). If you need to register for the webcast\, please contact Christina McCormick\, christina.mccormick@nih.gov. \nHighlighted agenda topics include: \n\nDefending against the Endemic Systemic Mycoses: Advances\, Challenges and Opportunities\nDesigning and Building the Next Generation of Vaccine Adjuvants\nHost Defense Against Dimorphic Fungal Pathogens: Critical Lessons from Inherited\nand Acquired Human Immunodeficiencies\nVaccines to Prevent Coccidioidomycosis: 60 Years and Counting\nChallenges in a Coccidiodal Vaccine Development\nUpdate in Histoplasmosis and Blastomycosis Epidemiology\nUpdate on Cross-Kingdom Vaccine: Scientific and Developmental Challenges\nNIAID Support for Vaccine Development\nImmunity to Valley Fever: Of Mice and Men\nAdjuvants for Fungal Vaccines\nEndemic Mycoses in Asia\nEpidemiology of Coccidioidomycosis in the United States: With New Insights from the Southern California Experience\nSpeciation of Coccidioides and Potential Biomarkers\n\nPlease visit the Vaccine Strategies for Endemic Fungal Pathogens website for more information.
URL:https://globalbiodefense.com/event/vaccine-strategies-for-endemic-fungal-pathogens/
LOCATION:Webinar
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190220
DTEND;VALUE=DATE:20190221
DTSTAMP:20190429T044315Z
CREATED:20190121T182518Z
LAST-MODIFIED:20190429T044315Z
UID:20647-1550620800-1550707199@globalbiodefense.com
SUMMARY:Mass Drug Administration and Antimicrobial Resistance
DESCRIPTION:The London School of Hygiene & Tropical Medicine Antimicrobial Resistance Center\, together with the MARCH and Malaria Centres will jointly host the Mass Drug Administration and Antimicrobial Resistance Symposium on 20 February 2019 in London\, UK and by live stream. \nMass Drug Administration is an intervention proposed to reduce morbidity and mortality of entire populations. This symposium will bring together academics from a range of relevant disciplines to discuss the state of evidence\, and draw out a future integrated research agenda that addresses potential hurdles with this approach\, including concerns about antimicrobial resistance. \nPlease visit the LSHTM Antimicrobial Resistance Centre’s website for more information.
URL:https://globalbiodefense.com/event/mass-drug-administration-antimicrobial-resistance/
LOCATION:John Snow Lecture Theatre – LSHTM\, Keppel Street\, London\, WC1E 7HT\, United Kingdom
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/mass-drug-administration-amr-lshtm.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190205T103000
DTEND;TZID=America/New_York:20190205T153000
DTSTAMP:20190125T022341Z
CREATED:20190115T023245Z
LAST-MODIFIED:20190125T022341Z
UID:20475-1549362600-1549380600@globalbiodefense.com
SUMMARY:Fighting the Next War: Defense Against Biological Weapons
DESCRIPTION:The Blue Ribbon Study Panel on Biodefense will host an in-depth discussion on the role of the U.S. Defense Department in biodefense on February 5th\, 2019 in Washington\, DC. \nParticipants will share their experiences regarding the current threat environment\, research and development programs\, and the Department’s biodefense policies. \nRSVP by January 30\, 2019. Attendance is free\, but registration is required. This event will also be webcast.
URL:https://globalbiodefense.com/event/fighting-the-next-war-defense-against-biological-weapons/
LOCATION:Council on Foreign Relations\, 1777 F Street\, NW\, Washington\, DC\, 20006\, United States
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/blue-ribbon-study-panel-biodefense.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190204
DTEND;VALUE=DATE:20190205
DTSTAMP:20190121T195504Z
CREATED:20190121T195112Z
LAST-MODIFIED:20190121T195504Z
UID:21908-1549238400-1549324799@globalbiodefense.com
SUMMARY:National Toxicology Program Peer-Review Meeting on Effects of Sarin Exposure
DESCRIPTION:The National Toxicology Program will host a public webinar on 4 Feb 2019 to discuss the draft findings of a systematic review to evaluate the evidence for long-term neurological effects in humans and animals following acute exposure to sarin. \nSarin is a highly toxic organophosphorus nerve agent that was developed for chemical warfare during World War II and continues to be used as a weapon. Long-term neurological effects of acute exposure to sarin are not well characterized. \nRegistration is required for attendance and to present oral comments. The webcast is open to the public. \nLearn more: Long-Term Effects Following Acute Exposure to Sarin Nerve Agent
URL:https://globalbiodefense.com/event/peer-review-meeting-on-long-term-effects-of-nerve-agent-exposure/
LOCATION:Webinar
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/sarin-nerve-agent.png
END:VEVENT
END:VCALENDAR